The process of co-positioning pharmaceutical products should begin early in the development phase to be successful.

Failure to accurately co-position products within a portfolio can lead to not maximizing the portfolio's commercial potential.

To encourage collaborative behavior, employee incentives in pharmaceutical companies should be based on portfolio maximization rather than the success of individual brands.